1) Klein, N. P. et al. : Waning protection after fifth dose of acellular pertussis vaccine in children. N. Engl. J. Med., 367 : 1012-1019, 2012
2) Centers for Disease Control and Prevention (CDC). : Pertussis epidemic : Washington, MMWR Morb. Mortal. Wkly Rep., 61 : 517-522, 2012
3) 総務省統計局の『伝染病及び食中毒の患者数と死亡者数』, http://www.stat.go.jp/data/chouki/zuhyou/24-10.xls
4) 国立感染症研究所感染症疫学センターの『感染症発生動向調査年別報告数一覧 (その2 : 定点把握) 』, http://www.nih.go.jp/niid/ja/all-surveillance/2085-idwr/ydata/3228-report-jb2011.html
5) 国立感染症研究所の百日咳発生DB (データベース), http://www.nih.go.jp/niid/ja/pertussis-m/610-idsc/561-pertu-db.html
6) Mattoo, S. & Cherry, J. D. : Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev., 18 : 326-382, 2005
7) Kuwae, A. et al. : BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death. J. Biol. Chem., 281 : 6589-6600, 2006
8) Nagamatsu, K. et al. : Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J. Exp. Med., 206 : 3073-3088, 2009
9) Kurushima, J. et al. : The type III secreted protein BspR regulates the virulence genes in Bordetella bronchiseptica. PLoS One, 7 : e38925, 2012